Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Inge Henter

Showing results (151-160 of 201) with videos related to

Pageof 21
Sort By:
Blood|September 23, 2017
Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 studyElisabet Bergsten, AnnaCarin Horne, Maurizio Aricó, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 12, 2018
Recommendations for the Use of Etoposide-Based Therapy and Bone Marrow Transplantation for the Treatment of HLH: Consensus Statements by the HLH Steering Committee of the Histiocyte SocietyStephan Ehl, Itziar Astigarraga, Tatiana von Bahr Greenwood, et al.
Clinics (Sao Paulo, Brazil)|May 12, 2016
Clinical presentation of hemophagocytic lymphohistiocytosis in adults is less typical than in childrenZuojuan Zhang, Juandong Wang, Buqiang Ji, et al.
Ebiomedicine|February 20, 2026
High-dimensional single-cell analyses reveal neutrophil heterogeneity in guttate psoriasisAvinash Padhi, Anoop T Ambikan, Panagiotis Andriopoulos, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2008
Mice lacking asparaginyl endopeptidase develop disorders resembling hemophagocytic syndromeChi-Bun Chan, Michiyo Abe, Noriyoshi Hashimoto, et al.
Blood|July 22, 2015
Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 studyJean Donadieu, Frederic Bernard, Max van Noesel, et al.
Archivum Immunologiae Et Therapiae Experimentalis|October 22, 2021
Molecular Genetics Diversity of Primary Hemophagocytic Lymphohistiocytosis among Polish Pediatric PatientsKatarzyna Bąbol-Pokora, Magdalena Wołowiec, Katarzyna Popko, et al.
Blood Advances|May 8, 2026
Disease Extent, Not Lesion Location, Determines Relapse Risk in Single-System Skeletal Langerhans Cell HistiocytosisItziar Astigarraga, Helga Björk Arnardóttir, Oussama Abla, et al.
Blood|August 26, 2009
Different NK cell-activating receptors preferentially recruit Rab27a or Munc13-4 to perforin-containing granules for cytotoxicityStephanie M Wood, Marie Meeths, Samuel C C Chiang, et al.
Haematologica|March 16, 2023
Myeloid cells from Langerhans cell histiocytosis patients exhibit increased vesicle trafficking and an altered secretome capable of activating NK cellsDaniel W Hagey, Egle Kvedaraite, Mira Akber, et al.
Pageof 21

Showing results (151-160 of 201) with videos related to

Sort By:
Pageof 21
Blood|September 23, 2017
Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 studyElisabet Bergsten, AnnaCarin Horne, Maurizio Aricó, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 12, 2018
Recommendations for the Use of Etoposide-Based Therapy and Bone Marrow Transplantation for the Treatment of HLH: Consensus Statements by the HLH Steering Committee of the Histiocyte SocietyStephan Ehl, Itziar Astigarraga, Tatiana von Bahr Greenwood, et al.
Clinics (Sao Paulo, Brazil)|May 12, 2016
Clinical presentation of hemophagocytic lymphohistiocytosis in adults is less typical than in childrenZuojuan Zhang, Juandong Wang, Buqiang Ji, et al.
Ebiomedicine|February 20, 2026
High-dimensional single-cell analyses reveal neutrophil heterogeneity in guttate psoriasisAvinash Padhi, Anoop T Ambikan, Panagiotis Andriopoulos, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2008
Mice lacking asparaginyl endopeptidase develop disorders resembling hemophagocytic syndromeChi-Bun Chan, Michiyo Abe, Noriyoshi Hashimoto, et al.
Blood|July 22, 2015
Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 studyJean Donadieu, Frederic Bernard, Max van Noesel, et al.
Archivum Immunologiae Et Therapiae Experimentalis|October 22, 2021
Molecular Genetics Diversity of Primary Hemophagocytic Lymphohistiocytosis among Polish Pediatric PatientsKatarzyna Bąbol-Pokora, Magdalena Wołowiec, Katarzyna Popko, et al.
Blood Advances|May 8, 2026
Disease Extent, Not Lesion Location, Determines Relapse Risk in Single-System Skeletal Langerhans Cell HistiocytosisItziar Astigarraga, Helga Björk Arnardóttir, Oussama Abla, et al.
Blood|August 26, 2009
Different NK cell-activating receptors preferentially recruit Rab27a or Munc13-4 to perforin-containing granules for cytotoxicityStephanie M Wood, Marie Meeths, Samuel C C Chiang, et al.
Haematologica|March 16, 2023
Myeloid cells from Langerhans cell histiocytosis patients exhibit increased vesicle trafficking and an altered secretome capable of activating NK cellsDaniel W Hagey, Egle Kvedaraite, Mira Akber, et al.
Pageof 21